论文部分内容阅读
目的:观察杀胚方联合西药综合干预治疗异位妊娠的临床疗效。方法:将80例未破裂型异位妊娠患者随机分为2组各40例,对照组予甲氨蝶呤注射液治疗,观察组在对照组治疗的基础上联合杀胚方治疗,观察比较2组患者血β人绒毛膜促性腺激素(β-HCG)复常时间、腹痛消失时间、盆腔包块直径大小、临床疗效及不良反应,并统计有生育要求者输卵管通畅度情况。结果:总有效率观察组为77.5%,对照组为50.0%,2组比较,差异有统计学意义(P<0.05)。治疗后观察组血β-HCG复常、腹痛消失时间短于对照组,包块直径小于对照组,差异均有统计学意义(P<0.01)。有生育要求患者输卵管通畅率观察组为94.44%,对照组为56.25%,2组比较,差异有统计学意义(P<0.05)。结论:杀胚方联合西药综合干预综合治疗异位妊娠疗效显著,可加速包块消失,促进其生殖功能恢复。
Objective: To observe the clinical efficacy of KBS combined with western medicine in the treatment of ectopic pregnancy. Methods: 80 cases of unruptured ectopic pregnancy were randomly divided into two groups of 40 cases, the control group methotrexate injection treatment group in the control group on the basis of combination therapy to kill embryo, the observation and comparison 2 Group of patients with serum β-human chorionic gonadotropin (β-HCG) recovery time, abdominal pain disappear time, pelvic mass size, clinical efficacy and adverse reactions, and statistical requirements of fertility tubal patency. Results: The total effective rate was 77.5% in the observation group and 50.0% in the control group. There was significant difference between the two groups (P <0.05). After treatment, the serum levels of β-HCG and disappearance of abdominal pain in observation group were shorter than those in control group, and the diameter of mass was smaller than that in control group (P <0.01). Patients with fertility requirements tubal patency in the observation group was 94.44%, 56.25% in the control group, the two groups, the difference was statistically significant (P <0.05). Conclusion: The combination of KBS and western medicine comprehensive treatment of ectopic pregnancy comprehensive treatment significantly, can accelerate the disappearance of mass, and promote their reproductive function recovery.